EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY

Journal Title: International Journal of Medical Reviews and Case Reports - Year 2018, Vol 2, Issue 4

Abstract

Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed by anequilibrium between type 1 cytokines including Interleukin-12 (IL-12); with type 2 cytokines such as Interleukin-4 (IL-4). Currently, the World Health Organization (WHO) recommends 3 leprosy treatment regimens, one of them is Rifampicin Ofloxacin Minocycline (ROM). To date, studies on the effects of ROM on leprosy have been limited, none have specifically assessed the effects of ROM on specific immune systems, especially cytokines. Methods: The study was conducted by prospective research method. The sample of this research were all multibacillary (MB) type of leprosy patients according to WHO classification who had received ROM therapy and recorded as the patient at research location and had medical record previous of interleukin-12 and interleukin-4 levels. After 12 months of ROM therapy, blood samples were collected and calculated using the Enzyme-Linked Immunosorbent Assay (ELISA) using the Quantikine® high sensitivity (HSv) kit. Results: There was a statistically significant increase in IL-4 after 12 months of a 3-months-ROM therapy. In contrast, the levels of IL-12 after 12 months showed significant decreases. Conclusions: Increased levels of IL-4 and decreased IL-12 can be caused by many factors. Therefore, further research with a closer supervision is required.

Authors and Affiliations

Eman Arif Rahman, Sri Vitayani Muchtar, Farida Tabri, Siswanto Wahab, Anni Adriani, Arifin Seweng, Rizalinda Sjahril

Keywords

Related Articles

Kikuchi-Fujimoto disease: case report and review

OBJECTIVE: The development of associated febrile to lymphadenomegaly leads to several diagnostic hypotheses, among them the Kikushi-Fujimoto disease. METHOD: This review was set up by searching PubMed/Medline, Web of Sc...

EFFECTIVNESS OF GLUTATHIONE (GSH) 2%, TOCOPHERYL ACETATE 1%, AND MAGNESIUM ASCORBYL PHOSPHATE 3% COMBINATION CREAM COMPARED WITH HYDROQUINONE 4% CREAM AS A SKIN LIGHTENING AGENT: A RANDOMISED STUDY

Black spots and brown spots interfere with aesthetic appearance. For this reason, there are various skin lightening products on the market, such as glutathione, vitamin C, and E. The combination of glutathione, vitamin C...

Glial Cells Involvement in Pathogenesis of Human Immunodeficiency Virus-Associated Sensory Neuropathy (HIV-SN): Literature Review

The sexually transmitted disease especially HIV infection is one of the global burdens. In Indonesia (2015), approximately 735.000 people were living with HIV/AIDS. Besides its comorbidity of opportunity infection, we sh...

EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY

Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed...

SUCCESSFUL MANAGEMENT OF RADIAL NERVE PARALYSIS IN A 2 YEAR-OLD MONGREL

A 2 year-old mongrel was presented to the Veterinary teaching hospital, University of Ibadan with knuckling of the right forelimb. The client gave history of automobile accident. The animal was clinically evaluated with...

Download PDF file
  • EP ID EP534634
  • DOI 10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS
  • Views 129
  • Downloads 0

How To Cite

Eman Arif Rahman, Sri Vitayani Muchtar, Farida Tabri, Siswanto Wahab, Anni Adriani, Arifin Seweng, Rizalinda Sjahril (2018). EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. International Journal of Medical Reviews and Case Reports, 2(4), 161-165. https://europub.co.uk/articles/-A-534634